Home›Companies›Biotech & Pharma›Cybele Microbiome

Cybele Microbiome, Inc.

Updated Oct 29, 2026·Latest SEC filing Mar 1, 2024·Suggest an edit

About Cybele Microbiome

Cybele Microbiome is a private company based in San Diego, California. It has reported $1,646,377 raised in four offerings on Form D since November 2022. Its chief executive is Nicole Scott.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 20, 2024Mar 1, 2024$252,000of $500K target5$50,400Debt, Securities on exerciseRule 506(b)Form D ↗
Dec 19, 2018Feb 9, 2023$877fully sold19$46EquityRule 506(b)Form D ↗
Nov 4, 2022Nov 16, 2022$500,000of $1.0M target1$500KDebt, Securities on exerciseRule 506(b)Form D ↗
Oct 28, 2018Nov 14, 2022$893,500fully sold19$47,026Options, Securities on exerciseRule 506(b)Form D ↗
Total, four offerings$1,646,377

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Cybele Microbiome's Form D filed Mar 1, 2024.

NS
Nicole Scott
Chief Executive Officer and director

Sources

  1. SECCybele Microbiome, Inc. filing history